Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Vomiting 8Nausea 5Neoplasms 2Lymphoma 2Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Postoperative Nausea and Vomiting 1Post-Dural Puncture Headache 1Multiple Myeloma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 22Radiotherapy 15Cetuximab 12Docetaxel 11Carboplatin 10pembrolizumab 8toripalimab 6camrelizumab 6Paclitaxel 5Nivolumab 5Neoadjuvant Therapy 5Fluorouracil 5Drug Therapy 5Chemoradiotherapy 5nimotuzumab 4durvalumab 4Blood Specimen Collection 4sintilimab 3cemiplimab 3apatinib 3advexin 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Immunohistochemistry 3Celecoxib 3nedaplatin 2Therapeutics 2Tegafur 2Radiotherapy, Intensity-Modulated 2Methotrexate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Squamous Cell Carcinoma of Head and Neck × Aprepitant × Clear all
NCT05202275 2022-01-21

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

ChineseAMS

Phase 2 Unknown
43 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡